#cirrhosis

MASLD and MASH can lead to liver fibrosis, cirrhosis and liver cancer.

An increase in fatty liver disease could double liver cancer cases and nearly triple the need for transplants by 2050.

Switching from meat to plant or dairy protein may reduce ammonia generation in those with cirrhosis.

Offering hepatitis C treatment at the point of diagnosis streamlines care, saving both time and money.

Egypt has diagnosed 87% of people living with hepatitis C and provided curative treatment for 93% of those diagnosed.

However, researchers saw little difference across racial groups in HBV treatment initiation among those who were eligible.

Coffee has numerous health benefits, but too much caffeine can cause problems.

NAFLD is associated with risk factors such as obesity and inflammatory biomarkers and with events including heart attacks and strokes.

In 2018, Black and Latino patients with advanced cirrhosis had a higher risk of mortality compared with white people.

Modern antivirals can cure 95% of people with HCV, lowering the risk of cirrhosis, liver cancer and liver failure.

Older people, men and people living in poverty and lacking private insurance were more likely to have active HCV infection.

The CDC estimates that 21% of people living with HIV also have hepatitis C virus.

Drug-related mortality, including overdose, was the leading cause of death.

For people with NAFLD or NASH, treating metabolic problems may offer benefits beyond liver disease.

In 2022, fatty liver disease accounted for nearly a quarter of all liver cancer cases on the transplant waiting list.